{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:33:56Z","timestamp":1794562436035,"version":"4.9.1"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100016714","name":"University of Sharjah","doi-asserted-by":"crossref","award":["24010902153"],"award-info":[{"award-number":["24010902153"]}],"id":[{"id":"10.13039\/100016714","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-025-01167-w","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:06:00Z","timestamp":1763640360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["\u03b1-synuclein in Parkinson\u2019s disease: a central point of convergence with depression"],"prefix":"10.1038","volume":"11","author":[{"given":"Ayesha M.","family":"Yusuf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcu Yener","family":"Ilce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid A.","family":"Alhaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifat","family":"Hamoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"1167_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet 386, 896\u2013912 (2015).","journal-title":"Lancet"},{"key":"1167_CR2","unstructured":"Stoker, T. B. & Greenland, J. C. Parkinson\u2019s disease: pathogenesis and clinical aspects [internet]. (2018)."},{"key":"1167_CR3","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/brain\/awx035","volume":"140","author":"A Lees","year":"2017","unstructured":"Lees, A. An essay on the shaking palsy. Brain 140, 843\u2013848 (2017).","journal-title":"Brain"},{"key":"1167_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00622-7","volume":"18","author":"T Koeglsperger","year":"2023","unstructured":"Koeglsperger, T. et al. Neuropathology of incidental Lewy body & prodromal Parkinson\u2019s disease. Mol. Neurodegen. 18, 32 (2023).","journal-title":"Mol. Neurodegen."},{"key":"1167_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/mds.23455","volume":"26","author":"GM Halliday","year":"2011","unstructured":"Halliday, G. M. & Stevens, C. H. Glia: initiators and progressors of pathology in Parkinson\u2019s disease. Mov. Disord. 26, 6\u201317 (2011).","journal-title":"Mov. Disord."},{"key":"1167_CR6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi, P. et al. Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis. 14, 176 (2023).","journal-title":"Cell Death Dis."},{"key":"1167_CR7","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/ene.13919","volume":"26","author":"R Durcan","year":"2019","unstructured":"Durcan, R. et al. Prevalence and duration of non-motor symptoms in prodromal Parkinson\u2019s disease. Eur. J. Neurol. 26, 979\u2013985 (2019).","journal-title":"Eur. J. Neurol."},{"key":"1167_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41983-019-0122-7","volume":"56","author":"EM Khedr","year":"2020","unstructured":"Khedr, E. M., Abdelrahman, A. A., Elserogy, Y., Zaki, A. F. & Gamea, A. Depression and anxiety among patients with Parkinson\u2019s disease: frequency, risk factors, and impact on quality of life. Egypt. J. Neurol., Psychiatry Neurosurg. 56, 1\u20139 (2020).","journal-title":"Egypt. J. Neurol., Psychiatry Neurosurg."},{"key":"1167_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak, H., Ghebremedhin, E., R\u00fcb, U., Bratzke, H. & Del Tredici, K. Stages in the development of Parkinson\u2019s disease-related pathology. Cell tissue Res. 318, 121\u2013134 (2004).","journal-title":"Cell tissue Res."},{"key":"1167_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-019-0329-1","volume":"14","author":"RM Meade","year":"2019","unstructured":"Meade, R. M., Fairlie, D. P. & Mason, J. M. Alpha-synuclein structure and Parkinson\u2019s disease\u2013lessons and emerging principles. Mol. Neurodegen. 14, 1\u201314 (2019).","journal-title":"Mol. Neurodegen."},{"key":"1167_CR11","doi-asserted-by":"crossref","unstructured":"Park, J. et al. Dexamethasone induces the expression of LRRK2 and a-synuclein, two genes that when mutated cause Parkinson is disease in an autosomal dominant manner. Biochem. Mol. Biol. Rep. 46 (2013).","DOI":"10.5483\/BMBRep.2013.46.9.234"},{"key":"1167_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-024-01797-w","volume":"12","author":"M Nakos Bimpos","year":"2024","unstructured":"Nakos Bimpos, M. et al. Alpha-synuclein-induced stress sensitivity renders the Parkinson\u2019s disease brain susceptible to neurodegeneration. Acta Neuropathol. Commun. 12, 100 (2024).","journal-title":"Acta Neuropathol. Commun."},{"key":"1167_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2019.08.007","volume":"83","author":"J Burtscher","year":"2019","unstructured":"Burtscher, J. et al. Chronic corticosterone aggravates behavioral and neuronal symptomatology in a mouse model of alpha-synuclein pathology. Neurobiol. aging 83, 11\u201320 (2019).","journal-title":"Neurobiol. aging"},{"key":"1167_CR14","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1111\/j.1460-9568.2007.05757.x","volume":"26","author":"AM Jeannotte","year":"2007","unstructured":"Jeannotte, A. M. & Sidhu, A. Regulation of the norepinephrine transporter by \u03b1-synuclein-mediated interactions with microtubules. Eur. J. Neurosci. 26, 1509\u20131520 (2007).","journal-title":"Eur. J. Neurosci."},{"key":"1167_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1600-0404.2007.00986.x","volume":"117","author":"S P\u00e5lhagen","year":"2008","unstructured":"P\u00e5lhagen, S., Carlsson, M., Curman, E., W\u00e5linder, J. & Gran\u00e9rus, A. K. Depressive illness in Parkinson\u2019s disease\u2013indication of a more advanced and widespread neurodegenerative process? Acta Neurol. Scand. 117, 295\u2013304 (2008).","journal-title":"Acta Neurol. Scand."},{"key":"1167_CR16","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.neurobiolaging.2014.02.009","volume":"35","author":"M Bungeroth","year":"2014","unstructured":"Bungeroth, M. et al. Differential aggregation properties of alpha-synuclein isoforms. Neurobiol. aging 35, 1913\u20131919 (2014).","journal-title":"Neurobiol. aging"},{"key":"1167_CR17","doi-asserted-by":"publisher","first-page":"22680","DOI":"10.1074\/jbc.M101181200","volume":"276","author":"MS Nielsen","year":"2001","unstructured":"Nielsen, M. S., Vorum, H., Lindersson, E. & Jensen, P. H. Ca2+ binding to \u03b1-synuclein regulates ligand binding and oligomerization. J. Biol. Chem. 276, 22680\u201322684 (2001).","journal-title":"J. Biol. Chem."},{"key":"1167_CR18","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1126\/science.1195227","volume":"329","author":"J Burr\u00e9","year":"2010","unstructured":"Burr\u00e9, J. et al. \u03b1-Synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329, 1663\u20131667 (2010).","journal-title":"Science"},{"key":"1167_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","volume":"18","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier, D. J., Obeso, J. A. & Halliday, G. M. Selective neuronal vulnerability in Parkinson disease. Nat. Rev. Neurosci. 18, 101\u2013113 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"1167_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature10324","volume":"477","author":"T Bartels","year":"2011","unstructured":"Bartels, T., Choi, J. G. & Selkoe, D. J. \u03b1-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477, 107\u2013110 (2011).","journal-title":"Nature"},{"key":"1167_CR21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fnmol.2014.00042","volume":"7","author":"S Tenreiro","year":"2014","unstructured":"Tenreiro, S., Eckermann, K. & Outeiro, T. F. Protein phosphorylation in neurodegeneration: friend or foe? Front. Mol. Neurosci. 7, 42 (2014).","journal-title":"Front. Mol. Neurosci."},{"key":"1167_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4827","volume":"5","author":"G Fusco","year":"2014","unstructured":"Fusco, G. et al. Direct observation of the three regions in \u03b1-synuclein that determine its membrane-bound behaviour. Nat. Commun. 5, 3827 (2014).","journal-title":"Nat. Commun."},{"key":"1167_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41531-018-0054-4","volume":"4","author":"F Zafar","year":"2018","unstructured":"Zafar, F. et al. Genetic fine-mapping of the Iowan SNCA gene triplication in a patient with Parkinson\u2019s disease. npj Parkinson\u2019s. Dis. 4, 18 (2018).","journal-title":"npj Parkinson\u2019s. Dis."},{"key":"1167_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1212\/01.wnl.0000271080.53272.c7","volume":"70","author":"T-B Ahn","year":"2008","unstructured":"Ahn, T.-B. et al. \u03b1-Synuclein gene duplication is present in sporadic Parkinson disease. Neurology 70, 43\u201349 (2008).","journal-title":"Neurology"},{"key":"1167_CR25","doi-asserted-by":"publisher","first-page":"5914","DOI":"10.3390\/ijms24065914","volume":"24","author":"G Forloni","year":"2023","unstructured":"Forloni, G. Alpha synuclein: neurodegeneration and inflammation. Int. J. Mol. Sci. 24, 5914 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1167_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.678373","volume":"12","author":"M Fernandes","year":"2021","unstructured":"Fernandes, M. et al. Frequency of non-motor symptoms in Parkinson\u2019s patients with motor fluctuations. Front. Neurol. 12, 678373 (2021).","journal-title":"Front. Neurol."},{"key":"1167_CR27","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.bbi.2021.03.020","volume":"95","author":"T Du","year":"2021","unstructured":"Du, T. et al. Hippocampal alpha-synuclein mediates depressive-like behaviors. Brain Behav. Immun. 95, 226\u2013237 (2021).","journal-title":"Brain Behav. Immun."},{"key":"1167_CR28","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.3390\/ijms20082029","volume":"20","author":"A Rotter","year":"2019","unstructured":"Rotter, A. et al. Alpha-synuclein RNA expression is increased in major depression. Int. J. Mol. Sci. 20, 2029 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"1167_CR29","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jagp.2018.10.015","volume":"27","author":"M Ishiguro","year":"2019","unstructured":"Ishiguro, M. et al. Increased serum levels of \u03b1-synuclein in patients with major depressive disorder. Am. J. Geriatr. Psychiatry 27, 280\u2013286 (2019).","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"1167_CR30","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/00207454.2020.1744596","volume":"131","author":"D Bruno","year":"2021","unstructured":"Bruno, D. et al. CSF \u03b1-synuclein correlates with CSF neurogranin in late-life depression. Int. J. Neurosci. 131, 357\u2013361 (2021).","journal-title":"Int. J. Neurosci."},{"key":"1167_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1130989","volume":"14","author":"S Hassamal","year":"2023","unstructured":"Hassamal, S. Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories. Front. Psychiatry 14, 1130989 (2023).","journal-title":"Front. Psychiatry"},{"key":"1167_CR32","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.3390\/cells12232726","volume":"12","author":"E Knezevic","year":"2023","unstructured":"Knezevic, E., Nenic, K., Milanovic, V. & Knezevic, N. N. The role of Cortisol in chronic stress, neurodegenerative diseases, and psychological disorders. Cells 12, 2726 (2023).","journal-title":"Cells"},{"key":"1167_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.bbi.2015.08.015","volume":"51","author":"S Sugama","year":"2016","unstructured":"Sugama, S. et al. Chronic restraint stress triggers dopaminergic and noradrenergic neurodegeneration: possible role of chronic stress in the onset of Parkinson\u2019s disease. Brain Behav. Immun. 51, 39\u201346 (2016).","journal-title":"Brain Behav. Immun."},{"key":"1167_CR34","doi-asserted-by":"crossref","unstructured":"DeMorrow, S. Vol. 19 986 (MDPI, 2018).","DOI":"10.3390\/ijms19040986"},{"key":"1167_CR35","doi-asserted-by":"crossref","unstructured":"Litwack, G. Chapter 15 - Polypeptide Hormones. Second edn, 475\u2013516 (Elsevier, 2022).","DOI":"10.1016\/B978-0-323-85718-5.00013-3"},{"key":"1167_CR36","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jpsychires.2007.11.008","volume":"42","author":"HA Alhaj","year":"2008","unstructured":"Alhaj, H. A., Massey, A. E. & McAllister-Williams, R. H. Effects of cortisol on the laterality of the neural correlates of episodic memory. J. Psychiatr. Res. 42, 971\u2013981 (2008).","journal-title":"J. Psychiatr. Res."},{"key":"1167_CR37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jpsychires.2006.08.008","volume":"41","author":"HA Alhaj","year":"2007","unstructured":"Alhaj, H. A., Massey, A. E. & McAllister-Williams, R. H. A study of the neural correlates of episodic memory and HPA axis status in drug-free depressed patients and healthy controls. J. Psychiatr. Res. 41, 295\u2013304 (2007).","journal-title":"J. Psychiatr. Res."},{"key":"1167_CR38","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1210\/js.2019-00158","volume":"3","author":"A-SC Koning","year":"2019","unstructured":"Koning, A.-S. C., Buurstede, J. C., van Weert, L. T. & Meijer, O. C. Glucocorticoid and mineralocorticoid receptors in the brain: a transcriptional perspective. J. Endocr. Soc. 3, 1917\u20131930 (2019).","journal-title":"J. Endocr. Soc."},{"key":"1167_CR39","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.pnpbp.2017.11.020","volume":"82","author":"GR Juszczak","year":"2018","unstructured":"Juszczak, G. R. & Stankiewicz, A. M. Glucocorticoids, genes and brain function. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 82, 136\u2013168 (2018).","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"1167_CR40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1021\/cn400167n","volume":"5","author":"SI Jenkins","year":"2014","unstructured":"Jenkins, S. I. et al. Identifying the cellular targets of drug action in the central nervous system following corticosteroid therapy. ACS Chem. Neurosci. 5, 51\u201363 (2014).","journal-title":"ACS Chem. Neurosci."},{"key":"1167_CR41","first-page":"2834","volume":"84","author":"D Franchimont","year":"1999","unstructured":"Franchimont, D. et al. Tumor necrosis factor \u03b1 decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor. J. Clin. Endocrinol. Metab. 84, 2834\u20132839 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1167_CR42","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1126\/science.270.5234.286","volume":"270","author":"N Auphan","year":"1995","unstructured":"Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A. & Karin, M. Immunosuppression by glucocorticoids: inhibition of NF-\u03baB activity through induction of I\u03baB synthesis. Science 270, 286\u2013290 (1995).","journal-title":"Science"},{"key":"1167_CR43","doi-asserted-by":"publisher","first-page":"e25849","DOI":"10.1371\/journal.pone.0025849","volume":"6","author":"KN Bushell","year":"2011","unstructured":"Bushell, K. N. et al. LITAF mediation of increased TNF-\u03b1 secretion from inflamed colonic lamina propria macrophages. PloS One 6, e25849 (2011).","journal-title":"PloS One"},{"key":"1167_CR44","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/npp.2012.225","volume":"38","author":"G Guidotti","year":"2013","unstructured":"Guidotti, G. et al. Glucocorticoid receptor and FKBP5 expression is altered following exposure to chronic stress: modulation by antidepressant treatment. Neuropsychopharmacology 38, 616\u2013627 (2013).","journal-title":"Neuropsychopharmacology"},{"key":"1167_CR45","doi-asserted-by":"publisher","first-page":"440","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_561_21","volume":"64","author":"MK Sahu","year":"2022","unstructured":"Sahu, M. K., Dubey, R. K., Chandrakar, A., Kumar, M. & Kumar, M. A systematic review and meta-analysis of serum and plasma cortisol levels in depressed patients versus control. Indian J. Psychiatry 64, 440\u2013448 (2022).","journal-title":"Indian J. Psychiatry"},{"key":"1167_CR46","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1016\/j.febslet.2011.09.010","volume":"585","author":"E Kumamaru","year":"2011","unstructured":"Kumamaru, E., Numakawa, T., Adachi, N. & Kunugi, H. Glucocorticoid suppresses BDNF-stimulated MAPK\/ERK pathway via inhibiting interaction of Shp2 with TrkB. FEBS Lett. 585, 3224\u20133228 (2011).","journal-title":"FEBS Lett."},{"key":"1167_CR47","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1139\/Y09-027","volume":"87","author":"J-M You","year":"2009","unstructured":"You, J.-M. et al. Mechanism of glucocorticoid-induced oxidative stress in rat hippocampal slice cultures. Can. J. Physiol. Pharmacol. 87, 440\u2013447 (2009).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"1167_CR48","doi-asserted-by":"publisher","first-page":"e00556","DOI":"10.1002\/brb3.556","volume":"6","author":"L H\u00e5glin","year":"2016","unstructured":"H\u00e5glin, L. & B\u00e4ckman, L. Covariation between plasma phosphate and daytime cortisol in early Parkinson\u2019s disease. Brain Behav. 6, e00556 (2016).","journal-title":"Brain Behav."},{"key":"1167_CR49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/mds.870050106","volume":"5","author":"VS Kosti\u0107","year":"1990","unstructured":"Kosti\u0107, V. S. et al. Dexamethasone suppression test in patients with Parkinson\u2019s disease. Mov. Disord.: J. Mov. Disord. Soc. 5, 23\u201326 (1990).","journal-title":"Mov. Disord.: J. Mov. Disord. Soc."},{"key":"1167_CR50","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/0006-3223(90)90525-7","volume":"27","author":"JM Rabey","year":"1990","unstructured":"Rabey, J. M., Scharf, M., Oberman, Z., Zohar, M. & Graff, E. Cortisol, ACTH, and beta-endorphin after dexamethasone administration in Parkinson\u2019s dementia. Biol. Psychiatry 27, 581\u2013591 (1990).","journal-title":"Biol. Psychiatry"},{"key":"1167_CR51","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00702-021-02451-8","volume":"129","author":"P \u0158\u00edha","year":"2022","unstructured":"\u0158\u00edha, P., Brabenec, L., Mare\u010dek, R., Rektor, I. & Rektorov\u00e1, I. The reduction of hippocampal volume in Parkinson\u2019s disease. J. Neural Transm. 129, 575\u2013580 (2022).","journal-title":"J. Neural Transm."},{"key":"1167_CR52","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jad.2015.05.029","volume":"183","author":"P Huang","year":"2015","unstructured":"Huang, P. et al. Abnormal amygdala function in Parkinson\u2019s disease patients and its relationship to depression. J. Affect. Disord. 183, 263\u2013268 (2015).","journal-title":"J. Affect. Disord."},{"key":"1167_CR53","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/mds.26112","volume":"30","author":"TJ van Mierlo","year":"2015","unstructured":"van Mierlo, T. J., Chung, C., Foncke, E. M., Berendse, H. W. & van den Heuvel, O. A. Depressive symptoms in Parkinson\u2019s disease are related to decreased hippocampus and amygdala volume. Mov. Disord. 30, 245\u2013252 (2015).","journal-title":"Mov. Disord."},{"key":"1167_CR54","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.3390\/cells9122565","volume":"9","author":"GR Jeong","year":"2020","unstructured":"Jeong, G. R. & Lee, B. D. Pathological functions of LRRK2 in Parkinson\u2019s disease. Cells 9, 2565 (2020).","journal-title":"Cells"},{"key":"1167_CR55","doi-asserted-by":"publisher","first-page":"454","DOI":"10.5483\/BMBRep.2013.46.9.234","volume":"46","author":"J-M Park","year":"2013","unstructured":"Park, J.-M. et al. Dexamethasone induces the expression of LRRK2 and \u03b1-synuclein, two genes that when mutated cause Parkinson\u2019s disease in an autosomal dominant manner. BMB Rep. 46, 454 (2013).","journal-title":"BMB Rep."},{"key":"1167_CR56","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.neuron.2009.11.006","volume":"64","author":"X Lin","year":"2009","unstructured":"Lin, X. et al. Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson\u2019s-disease-related mutant \u03b1-synuclein. Neuron 64, 807\u2013827 (2009).","journal-title":"Neuron"},{"key":"1167_CR57","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3233\/JPD-202465","volume":"11","author":"S Villar-Conde","year":"2021","unstructured":"Villar-Conde, S. et al. The human hippocampus in Parkinson\u2019s disease: an integrative stereological and proteomic study. J. Parkinson\u2019s. Dis. 11, 1345\u20131365 (2021).","journal-title":"J. Parkinson\u2019s. Dis."},{"key":"1167_CR58","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3389\/fnins.2018.01033","volume":"12","author":"Z Wassouf","year":"2019","unstructured":"Wassouf, Z. et al. Distinct stress response and altered striatal transcriptome in alpha-synuclein overexpressing mice. Front. Neurosci. 12, 1033 (2019).","journal-title":"Front. Neurosci."},{"key":"1167_CR59","first-page":"4","volume":"52","author":"E Azmitia","year":"1991","unstructured":"Azmitia, E. & Whitaker-Azmitia, P. Awakening the sleeping giant: anatomy and plasticity of the brain serotonergic system. J. Clin. Psychiatry 52, 4\u201316 (1991).","journal-title":"J. Clin. Psychiatry"},{"key":"1167_CR60","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"1167_CR61","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/S1474-4422(19)30140-1","volume":"18","author":"H Wilson","year":"2019","unstructured":"Wilson, H. et al. Serotonergic pathology and disease burden in the premotor and motor phase of A53T \u03b1-synuclein parkinsonism: a cross-sectional study. Lancet Neurol. 18, 748\u2013759 (2019).","journal-title":"Lancet Neurol."},{"key":"1167_CR62","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/0006-8993(90)90733-R","volume":"510","author":"G Halliday","year":"1990","unstructured":"Halliday, G., Blumbergs, P., Cotton, R., Blessing, W. & Geffen, L. Loss of brainstem serotonin-and substance P-containing neurons in Parkinson\u2019s disease. Brain Res. 510, 104\u2013107 (1990).","journal-title":"Brain Res."},{"key":"1167_CR63","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/sj.jcbfm.9600599","volume":"28","author":"RL Albin","year":"2008","unstructured":"Albin, R. L. et al. Spared caudal brainstem SERT binding in early Parkinson\u2019s disease. J. Cereb. Blood Flow. Metab. 28, 441\u2013444 (2008).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"1167_CR64","doi-asserted-by":"crossref","unstructured":"Bortolozzi, A. et al. Human \u03b1-synuclein overexpression in mouse serotonin neurons triggers a depressive-like. phenotype. Rescue by oligonucleotide therapy, (2021).","DOI":"10.21203\/rs.3.rs-725067\/v1"},{"key":"1167_CR65","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1177\/02698811231200881","volume":"37","author":"Y Mizuno","year":"2023","unstructured":"Mizuno, Y., Ashok, A. H., Bhat, B. B., Jauhar, S. & Howes, O. D. Dopamine in major depressive disorder: A systematic review and meta-analysis of in vivo imaging studies. J. Psychopharmacol. 37, 1058\u20131069 (2023).","journal-title":"J. Psychopharmacol."},{"key":"1167_CR66","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1046\/j.1460-9568.2000.00969.x","volume":"12","author":"E Isovich","year":"2000","unstructured":"Isovich, E., Mijnster, M. J., Fl\u00fcgge, G. & Fuchs, E. Chronic psychosocial stress reduces the density of dopamine transporters. Eur. J. Neurosci. 12, 1071\u20131078 (2000).","journal-title":"Eur. J. Neurosci."},{"key":"1167_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1008956","volume":"17","author":"F Dalvi-Garcia","year":"2021","unstructured":"Dalvi-Garcia, F., Fonseca, L. L., Vasconcelos, A. T. R., Hedin-Pereira, C. & Voit, E. O. A model of dopamine and serotonin-kynurenine metabolism in cortisolemia: Implications for depression. PLoS Comput. Biol. 17, e1008956 (2021).","journal-title":"PLoS Comput. Biol."},{"key":"1167_CR68","first-page":"166","volume":"2","author":"Y Agid","year":"1987","unstructured":"Agid, Y. Biochemistry of neurotransmitters in Parkinson\u2019s disease. Mov. Disord. 2, 166\u2013230 (1987).","journal-title":"Mov. Disord."},{"key":"1167_CR69","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1212\/WNL.35.4.565","volume":"35","author":"JH Hurst","year":"1985","unstructured":"Hurst, J. H., LeWitt, P. A., Burns, R. S., Foster, N. L. & Lovenberg, W. CSF dopamine\u2013hydroxylase activity in Parkinson\u2019s disease. Neurology 35, 565\u2013565 (1985).","journal-title":"Neurology"},{"key":"1167_CR70","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/brain\/awh445","volume":"128","author":"P Remy","year":"2005","unstructured":"Remy, P., Doder, M., Lees, A., Turjanski, N. & Brooks, D. Depression in Parkinson\u2019s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128, 1314\u20131322 (2005).","journal-title":"Brain"},{"key":"1167_CR71","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1212\/WNL.0b013e3182516244","volume":"78","author":"I Richard","year":"2012","unstructured":"Richard, I. et al. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology 78, 1229\u20131236 (2012).","journal-title":"Neurology"},{"key":"1167_CR72","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1517\/14656566.2012.736490","volume":"13","author":"U Bonuccelli","year":"2012","unstructured":"Bonuccelli, U. et al. A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson\u2019s disease. Expert Opin. Pharmacother. 13, 2269\u20132280 (2012).","journal-title":"Expert Opin. Pharmacother."},{"key":"1167_CR73","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s42485-022-00088-z","volume":"13","author":"S Lehrer","year":"2022","unstructured":"Lehrer, S. & Rheinstein, P. H. \u03b1-synuclein enfolds tyrosine hydroxylase and dopamine \u00df-hydroxylase, potentially reducing dopamine and norepinephrine synthesis. J. Proteins Proteom. 13, 109\u2013115 (2022).","journal-title":"J. Proteins Proteom."},{"key":"1167_CR74","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/npp.2008.146","volume":"34","author":"AM Jeannotte","year":"2009","unstructured":"Jeannotte, A. M., McCarthy, J. G., Redei, E. E. & Sidhu, A. Desipramine modulation of \u03b1-, \u03b3-synuclein, and the norepinephrine transporter in an animal model of depression. Neuropsychopharmacology 34, 987\u2013998 (2009).","journal-title":"Neuropsychopharmacology"},{"key":"1167_CR75","doi-asserted-by":"publisher","first-page":"878771","DOI":"10.3389\/fimmu.2022.878771","volume":"13","author":"A Grotemeyer","year":"2022","unstructured":"Grotemeyer, A., McFleder, R. L., Wu, J., Wischhusen, J. & Ip, C. W. Neuroinflammation in Parkinson\u2019s disease-putative pathomechanisms and targets for disease-modification. Front. Immunol. 13, 878771 (2022).","journal-title":"Front. Immunol."},{"key":"1167_CR76","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/ejn.14720","volume":"53","author":"R Troubat","year":"2021","unstructured":"Troubat, R. et al. Neuroinflammation and depression: A review. Eur. J. Neurosci. 53, 151\u2013171 (2021).","journal-title":"Eur. J. Neurosci."},{"key":"1167_CR77","doi-asserted-by":"crossref","unstructured":"Latham, A. S., Rocha, S. M., McDermott, C. P., Reigan, P. & Tjalkens, R. B. Neuroprotective efficacy of the glucocorticoid receptor modulator PT150 in the rotenone mouse model of Parkinsons disease. bioRxiv, 2024.2004. 2012.589261 (2024).","DOI":"10.1101\/2024.04.12.589261"},{"key":"1167_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04569-y","volume":"9","author":"L Maatouk","year":"2018","unstructured":"Maatouk, L. et al. TLR9 activation via microglial glucocorticoid receptors contributes to degeneration of midbrain dopamine neurons. Nat. Commun. 9, 2450 (2018).","journal-title":"Nat. Commun."},{"key":"1167_CR79","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1021\/acschemneuro.1c00095","volume":"12","author":"C Ren","year":"2021","unstructured":"Ren, C. et al. Depression induced by chronic unpredictable mild stress increases susceptibility to Parkinson\u2019s disease in mice via neuroinflammation mediated by P2X7 receptor. ACS Chem. Neurosci. 12, 1262\u20131272 (2021).","journal-title":"ACS Chem. Neurosci."},{"key":"1167_CR80","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1111\/ene.14918","volume":"28","author":"A Solini","year":"2021","unstructured":"Solini, A. et al. P2X7 receptor\/NLRP3 inflammasome complex and \u03b1-synuclein in peripheral blood mononuclear cells: a prospective study in neo-diagnosed, treatment-na\u00efve Parkinson\u2019s disease. Eur. J. Neurol. 28, 2648\u20132656 (2021).","journal-title":"Eur. J. Neurol."},{"key":"1167_CR81","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.3390\/ijms21113959","volume":"21","author":"A Wilkaniec","year":"2020","unstructured":"Wilkaniec, A. et al. P2X7 receptor is involved in mitochondrial dysfunction induced by extracellular alpha synuclein in neuroblastoma SH-SY5Y cells. Int. J. Mol. Sci. 21, 3959 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1167_CR82","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/glia.22610","volume":"62","author":"E Valera","year":"2014","unstructured":"Valera, E., Ubhi, K., Mante, M., Rockenstein, E. & Masliah, E. Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy. Glia 62, 317\u2013337 (2014).","journal-title":"Glia"},{"key":"1167_CR83","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neulet.2017.04.063","volume":"651","author":"Y Hao","year":"2017","unstructured":"Hao, Y., Shabanpoor, A. & Metz, G. A. Stress and corticosterone alter synaptic plasticity in a rat model of Parkinson\u2019s disease. Neurosci. Lett. 651, 79\u201387 (2017).","journal-title":"Neurosci. Lett."},{"key":"1167_CR84","doi-asserted-by":"publisher","first-page":"32701","DOI":"10.1073\/pnas.2013652117","volume":"117","author":"M Somayaji","year":"2020","unstructured":"Somayaji, M. et al. A dual role for \u03b1-synuclein in facilitation and depression of dopamine release from substantia nigra neurons in vivo. Proc. Natl. Acad. Sci. 117, 32701\u201332710 (2020).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"1167_CR85","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3390\/brainsci11081106","volume":"11","author":"S Claros","year":"2021","unstructured":"Claros, S. et al. Impact of glucocorticoid on a cellular model of Parkinson\u2019s disease: oxidative stress and mitochondrial function. Brain Sci. 11, 1106 (2021).","journal-title":"Brain Sci."},{"key":"1167_CR86","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1007\/s12035-019-01838-9","volume":"57","author":"M Grigoru\u0163\u0103","year":"2020","unstructured":"Grigoru\u0163\u0103, M., Mart\u00ednez-Mart\u00ednez, A., Dagda, R. Y. & Dagda, R. K. Psychological stress phenocopies brain mitochondrial dysfunction and motor deficits as observed in a parkinsonian rat model. Mol. Neurobiol. 57, 1781\u20131798 (2020).","journal-title":"Mol. Neurobiol."},{"key":"1167_CR87","doi-asserted-by":"publisher","first-page":"e1820","DOI":"10.1038\/cddis.2015.166","volume":"6","author":"A Reeve","year":"2015","unstructured":"Reeve, A. et al. Aggregated \u03b1-synuclein and complex I deficiency: exploration of their relationship in differentiated neurons. Cell Death Dis. 6, e1820\u2013e1820 (2015).","journal-title":"Cell Death Dis."},{"key":"1167_CR88","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/s41593-022-01140-3","volume":"25","author":"ML Choi","year":"2022","unstructured":"Choi, M. L. et al. Pathological structural conversion of \u03b1-synuclein at the mitochondria induces neuronal toxicity. Nat. Neurosci. 25, 1134\u20131148 (2022).","journal-title":"Nat. Neurosci."},{"key":"1167_CR89","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neulet.2015.08.032","volume":"606","author":"Z Wei","year":"2015","unstructured":"Wei, Z., Liao, J., Qi, F., Meng, Z. & Pan, S. Evidence for the contribution of BDNF-TrkB signal strength in neurogenesis: An organotypic study. Neurosci. Lett. 606, 48\u201352 (2015).","journal-title":"Neurosci. Lett."},{"key":"1167_CR90","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1038\/sj.cdd.4401662","volume":"12","author":"R Almeida","year":"2005","unstructured":"Almeida, R. et al. Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death Differ. 12, 1329\u20131343 (2005).","journal-title":"Cell Death Differ."},{"key":"1167_CR91","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1176\/appi.neuropsych.16040062","volume":"29","author":"FC Cagni","year":"2017","unstructured":"Cagni, F. C. et al. Association of BDNF Val66MET polymorphism with Parkinson\u2019s disease and depression and anxiety symptoms. J. neuropsychiatry Clin. Neurosci. 29, 142\u2013147 (2017).","journal-title":"J. neuropsychiatry Clin. Neurosci."},{"key":"1167_CR92","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00415-020-10299-3","volume":"268","author":"Y Huang","year":"2021","unstructured":"Huang, Y., Huang, C., Zhang, Q., Wu, W. & Sun, J. Serum BDNF discriminates Parkinson\u2019s disease patients with depression from without depression and reflect motor severity and gender differences. J. Neurol. 268, 1411\u20131418 (2021).","journal-title":"J. Neurol."},{"key":"1167_CR93","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.parkreldis.2017.05.012","volume":"41","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Association of low serum BDNF with depression in patients with Parkinson\u2019s disease. Parkinson. Relat. Disord. 41, 73\u201378 (2017).","journal-title":"Parkinson. Relat. Disord."},{"key":"1167_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-01842-z","volume":"12","author":"L Miquel-Rio","year":"2022","unstructured":"Miquel-Rio, L. et al. Human \u03b1-synuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype. Rescue by oligonucleotide therapy. Transl. Psychiatry 12, 79 (2022).","journal-title":"Transl. Psychiatry"},{"key":"1167_CR95","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s10571-010-9523-y","volume":"30","author":"Y Yuan","year":"2010","unstructured":"Yuan, Y. et al. Overexpression of \u03b1-synuclein down-regulates BDNF expression. Cell. Mol. Neurobiol. 30, 939\u2013946 (2010).","journal-title":"Cell. Mol. Neurobiol."},{"key":"1167_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtn.2022.05.037","volume":"29","author":"Q Cao","year":"2022","unstructured":"Cao, Q. et al. Suppression of abnormal \u03b1-synuclein expression by activation of BDNF transcription ameliorates Parkinson\u2019s disease-like pathology. Mol. Ther. -Nucleic Acids 29, 1\u201315 (2022).","journal-title":"Mol. Ther. -Nucleic Acids"},{"key":"1167_CR97","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S0924-9338(11)72190-3","volume":"26","author":"V Ricci","year":"2011","unstructured":"Ricci, V. et al. P01-479-Antidepressant treatment restores brain-derived neurotrophic factor (BDNF) serum levels and ameliorates motor function in parkinson\u2019s disease patients. Eur. Psychiatry 26, 483 (2011).","journal-title":"Eur. Psychiatry"},{"key":"1167_CR98","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.nbd.2015.10.021","volume":"85","author":"Z Kohl","year":"2016","unstructured":"Kohl, Z. et al. Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC \u03b1-synuclein transgenic rat model of Parkinson\u2019s disease. Neurobiol. Dis. 85, 206\u2013217 (2016).","journal-title":"Neurobiol. Dis."},{"key":"1167_CR99","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.euroneuro.2023.12.003","volume":"78","author":"R Mazurka","year":"2024","unstructured":"Mazurka, R. et al. Relation of hippocampal volume and SGK1 gene expression to treatment remission in major depression is moderated by childhood maltreatment: a CAN-BIND-1 report. Eur. Neuropsychopharmacol. 78, 71\u201380 (2024).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"1167_CR100","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.gene.2018.03.086","volume":"661","author":"S Yeo","year":"2018","unstructured":"Yeo, S. et al. Decreased expression of serum-and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cells. Gene 661, 189\u2013195 (2018).","journal-title":"Gene"},{"key":"1167_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."},{"key":"1167_CR102","volume":"2023","author":"Y Yong","year":"2023","unstructured":"Yong, Y. et al. Dyrk1a Phosphorylation of \u03b1-Synuclein Mediating Apoptosis of Dopaminergic Neurons in Parkinson\u2019s Disease. Parkinson\u2019s. Dis. 2023, 8848642 (2023).","journal-title":"Parkinson\u2019s. Dis."},{"key":"1167_CR103","first-page":"3822","volume":"55","author":"J London","year":"2018","unstructured":"London, J. et al. Overexpression of the DYRK1A gene (dual-specificity tyrosine phosphorylation-regulated kinase 1A) induces alterations of the serotoninergic and dopaminergic processing in murine brain tissues. Mol. Neurobiol. 55, 3822\u20133831 (2018).","journal-title":"Mol. Neurobiol."},{"key":"1167_CR104","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1016\/j.neuron.2023.07.015","volume":"111","author":"F Garretti","year":"2023","unstructured":"Garretti, F. et al. Interaction of an \u03b1-synuclein epitope with HLA-DRB1\u2217 15: 01 triggers enteric features in mice reminiscent of prodromal Parkinson\u2019s disease. Neuron 111, 3397\u20133413. e3395 (2023).","journal-title":"Neuron"},{"key":"1167_CR105","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neurobiolaging.2019.09.012","volume":"85","author":"J Zhang","year":"2020","unstructured":"Zhang, J. et al. Apoptosis signal regulating kinase 1 deletion mitigates \u03b1-synuclein pre-formed fibril propagation in mice. Neurobiol. aging 85, 49\u201357 (2020).","journal-title":"Neurobiol. aging"},{"key":"1167_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02479-x","volume":"19","author":"T Lan","year":"2022","unstructured":"Lan, T. et al. Agomelatine rescues lipopolysaccharide-induced neural injury and depression-like behaviors via suppression of the G\u03b1i-2-PKA-ASK1 signaling pathway. J. Neuroinflamm. 19, 117 (2022).","journal-title":"J. Neuroinflamm."},{"key":"1167_CR107","doi-asserted-by":"publisher","first-page":"6781","DOI":"10.3390\/ijms23126781","volume":"23","author":"Z Toleikis","year":"2022","unstructured":"Toleikis, Z. et al. Interactions between s100a9 and alpha-synuclein: insight from NMR spectroscopy. Int. J. Mol. Sci. 23, 6781 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1167_CR108","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-019-0247-x","volume":"13","author":"DR Lorenz","year":"2019","unstructured":"Lorenz, D. R., Misra, V. & Gabuzda, D. Transcriptomic analysis of monocytes from HIV-positive men on antiretroviral therapy reveals effects of tobacco smoking on interferon and stress response systems associated with depressive symptoms. Hum. Genomics 13, 59 (2019).","journal-title":"Hum. Genomics"},{"key":"1167_CR109","doi-asserted-by":"publisher","first-page":"583709","DOI":"10.3389\/fimmu.2020.583709","volume":"11","author":"AU Kraus","year":"2020","unstructured":"Kraus, A. U., Penna-Martinez, M., Shoghi, F., Meyer, G. & Badenhoop, K. Monocytic cytokines in autoimmune polyglandular syndrome type 2 are modulated by vitamin D and HLA-DQ. Front. Immunol. 11, 583709 (2020).","journal-title":"Front. Immunol."},{"key":"1167_CR110","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41531-021-00231-5","volume":"7","author":"E Yu","year":"2021","unstructured":"Yu, E. et al. Fine mapping of the HLA locus in Parkinson\u2019s disease in Europeans. npj Parkinson\u2019s. Dis. 7, 84 (2021).","journal-title":"npj Parkinson\u2019s. Dis."},{"key":"1167_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.136296","volume":"765","author":"S Pandi","year":"2021","unstructured":"Pandi, S. et al. Association of HLA\u2013DRB1, DQA1 and DQB1 alleles and haplotype in Parkinson\u2019s disease from South India. Neurosci. Lett. 765, 136296 (2021).","journal-title":"Neurosci. Lett."},{"key":"1167_CR112","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00210-023-02656-6","volume":"397","author":"HM Al-Kuraishy","year":"2024","unstructured":"Al-Kuraishy, H. M. et al. Does vitamin D protect or treat Parkinson\u2019s disease? A narrative review. Naunyn-Schmiedeberg\u2019s. Arch. Pharmacol. 397, 33\u201340 (2024).","journal-title":"Naunyn-Schmiedeberg\u2019s. Arch. Pharmacol."},{"key":"1167_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nutos.2023.09.005","volume":"52","author":"P Detopoulou","year":"2023","unstructured":"Detopoulou, P. et al. Vitamin D in Parkinson\u2019s disease: A systematic review of randomized controlled trials. Clin. Nutr. Open Sci. 52, 1\u201313 (2023).","journal-title":"Clin. Nutr. Open Sci."},{"key":"1167_CR114","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/mds.21803","volume":"23","author":"JS Reijnders","year":"2008","unstructured":"Reijnders, J. S., Ehrt, U., Weber, W. E., Aarsland, D. & Leentjens, A. F. A systematic review of prevalence studies of depression in Parkinson\u2019s disease. Mov. Disord. 23, 183\u2013189 (2008).","journal-title":"Mov. Disord."},{"key":"1167_CR115","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/0891988707301866","volume":"20","author":"P Chen","year":"2007","unstructured":"Chen, P. et al. Antidepressant treatment of veterans with Parkinson\u2019s disease and depression: analysis of a national sample. J. Geriatr. psychiatry Neurol. 20, 161\u2013165 (2007).","journal-title":"J. Geriatr. psychiatry Neurol."},{"key":"1167_CR116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2377-10-49","volume":"10","author":"P Skapinakis","year":"2010","unstructured":"Skapinakis, P. et al. Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson\u2019s disease: a systematic review and meta-analysis of randomized controlled trials. BMC Neurol. 10, 1\u201311 (2010).","journal-title":"BMC Neurol."},{"key":"1167_CR117","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-025-00490-9","volume":"14","author":"X Zhan","year":"2025","unstructured":"Zhan, X., Wen, G., Wu, X. & Li, J.-Y. Immunization targeting diseased proteins in synucleinopathy and tauopathy: insights from clinical trials. Transl. Neurodegen. 14, 33 (2025).","journal-title":"Transl. Neurodegen."},{"key":"1167_CR118","first-page":"395","volume":"33","author":"E Pena","year":"2018","unstructured":"Pena, E. et al. Antidepressants in Parkinson\u2019s disease. Recommendations by the movement disorder study group of the Neurological Association of Madrid. Neurol.\u00eda (Engl. Ed.) 33, 395\u2013402 (2018).","journal-title":"Neurol.\u00eda (Engl. Ed.)"},{"key":"1167_CR119","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.neurobiolaging.2014.07.034","volume":"36","author":"K-W Lee","year":"2015","unstructured":"Lee, K.-W. et al. Apoptosis signal-regulating kinase 1 modulates the phenotype of \u03b1-synuclein transgenic mice. Neurobiol. aging 36, 519\u2013526 (2015).","journal-title":"Neurobiol. aging"},{"key":"1167_CR120","first-page":"191","volume":"72","author":"AP Ilje\u0161","year":"2021","unstructured":"Ilje\u0161, A. P., Plesni\u010dar, B. K. & Dol\u017ean, V. Associations of NLRP3 and CARD8 gene polymorphisms with alcohol dependence and commonly related psychiatric disorders: a preliminary study. Arch. Ind. Hyg. Toxicol. 72, 191 (2021).","journal-title":"Arch. Ind. Hyg. Toxicol."},{"key":"1167_CR121","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403058","volume":"11","author":"LFR Qi","year":"2024","unstructured":"Qi, L. F. R. et al. Ginsenoside Rg3 restores mitochondrial Cardiolipin homeostasis via GRB2 to prevent Parkinson\u2019s disease. Adv. Sci. 11, 2403058 (2024).","journal-title":"Adv. Sci."},{"key":"1167_CR122","doi-asserted-by":"publisher","first-page":"200","DOI":"10.4103\/apjtb.apjtb_750_24","volume":"15","author":"Y Zeng","year":"2025","unstructured":"Zeng, Y. et al. Identification of potential biomarkers and pathways related to major depressive disorder by integrated bioinformatic analysis and experimental validation. Asian Pac. J. Trop. Biomed. 15, 200\u2013209 (2025).","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"1167_CR123","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1458476","volume":"16","author":"J Zhang","year":"2024","unstructured":"Zhang, J. et al. Identification of key genes and diagnostic model associated with circadian rhythms and Parkinson\u2019s disease by bioinformatics analysis. Front. Aging Neurosci. 16, 1458476 (2024).","journal-title":"Front. Aging Neurosci."},{"key":"1167_CR124","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/j.1440-1789.2010.01107.x","volume":"30","author":"JE Heath","year":"2010","unstructured":"Heath, J. E. et al. Widespread distribution of reticulon-3 in various neurodegenerative diseases. Neuropathology 30, 574\u2013579 (2010).","journal-title":"Neuropathology"},{"key":"1167_CR125","doi-asserted-by":"publisher","first-page":"299.e291","DOI":"10.1016\/j.neurobiolaging.2020.11.005","volume":"101","author":"C Li","year":"2021","unstructured":"Li, C. et al. Mutation analysis of TMEM family members for early-onset Parkinson\u2019s disease in Chinese population. Neurobiol. Aging 101, 299.e291\u2013299.e296 (2021).","journal-title":"Neurobiol. Aging"},{"key":"1167_CR126","doi-asserted-by":"publisher","first-page":"105382","DOI":"10.1016\/j.jsbmb.2019.105382","volume":"192","author":"AK Manjur","year":"2019","unstructured":"Manjur, A. K., Lempi\u00e4inen, J. K., Malinen, M., Palvimo, J. J. & Niskanen, E. A. IRF2BP2 modulates the crosstalk between glucocorticoid and TNF signaling. J. Steroid Biochem. Mol. Biol. 192, 105382 (2019).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"1167_CR127","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neulet.2016.08.022","volume":"632","author":"L Cen","year":"2016","unstructured":"Cen, L. et al. Association of DYRK1A polymorphisms with sporadic Parkinson\u2019s disease in Chinese Han population. Neurosci. Lett. 632, 39\u201343 (2016).","journal-title":"Neurosci. Lett."},{"key":"1167_CR128","doi-asserted-by":"publisher","first-page":"e1289","DOI":"10.1038\/cddis.2014.253","volume":"5","author":"M-J Barallobre","year":"2014","unstructured":"Barallobre, M.-J. et al. DYRK1A promotes dopaminergic neuron survival in the developing brain and in a mouse model of Parkinson\u2019s disease. Cell Death Dis. 5, e1289\u2013e1289 (2014).","journal-title":"Cell Death Dis."},{"key":"1167_CR129","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bbrc.2022.12.082","volume":"644","author":"T Ozono","year":"2023","unstructured":"Ozono, T. et al. Extracellular transportation of \u03b1-synuclein by HLA class II molecules. Biochem. Biophys. Res. Commun. 644, 25\u201333 (2023).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1167_CR130","doi-asserted-by":"publisher","DOI":"10.1111\/tan.15173","volume":"103","author":"B Cheng","year":"2024","unstructured":"Cheng, B. et al. Associations of classical HLA alleles with depression and anxiety. Hla 103, e15173 (2024).","journal-title":"Hla"},{"key":"1167_CR131","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/s41380-022-01919-7","volume":"28","author":"\u00c9M Foley","year":"2023","unstructured":"Foley, \u00c9. M., Parkinson, J. T., Mitchell, R. E., Turner, L. & Khandaker, G. M. Peripheral blood cellular immunophenotype in depression: a systematic review and meta-analysis. Mol. Psychiatry 28, 1004\u20131019 (2023).","journal-title":"Mol. Psychiatry"}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01167-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01167-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01167-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:06:01Z","timestamp":1763643961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01167-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":131,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1167"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-01167-w","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"329"}}